(Bloomberg) -- Reckitt Benckiser Plc is ramping up manufacturing in the US and China to bolster its supply chain and potentially lessen its exposure to fresh trade wars. The maker of Strepsils ...

Private equity firms Advent, Apollo Global (APO) and Lone Star Fund are among buyout firms bidding for homecare assets being sold by Reckitt Benckiser (OTCPK:RBGPF). Reckitt (OTCPK:RBGPF ...

Reckitt Benckiser's shares rose after the company said adjusted profit beat market expectations, despite lower sales, as it continues to progress with its turnaround plans. Shares in morning trade ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...

Key Insights Reckitt Benckiser Group's estimated fair value is UK£81.40 based on 2 Stage Free Cash Flow to Equity... The new facility will help to boost Reckitt's production of Mucinex cold and ...

The majority of Reckitt’s portfolio is well positioned in categories that benefit from secular growth drivers across consumer health and hygiene. The acquisition of Mead Johnson has added to its ...

Based on the last payment, Reckitt Benckiser Group's profits didn't cover the dividend, but the company was generating enough cash instead. Generally, we think cash is more important than ...

Reckitt Benckiser’s RKT1.43%increase; green up pointing triangle shares rose after the company said adjusted profit beat market expectations, despite lower sales, as it continues to progress ...

As trade war intensifies, Reckitt may be more exposed than some rivals Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low ...